Why the study?
Postoperative atrial fibrillation is common after cardiac surgery, and while invasive vagal nerve stimulation reduces risk, the antiarrhythmic and anti-inflammatory effects of noninvasive low-level transcutaneous electrical stimulation of the greater auricular nerve were unexamined.
Does noninvasive low-level transcutaneous electrical stimulation of the greater auricular nerve reduce postoperative atrial fibrillation in patients undergoing cardiac surgery?
Does noninvasive low-level transcutaneous electrical stimulation of the greater auricular nerve reduce postoperative atrial fibrillation in patients undergoing cardiac surgery?
Noninvasive low-level transcutaneous electrical stimulation of the greater auricular nerve significantly reduced the occurrence of postoperative atrial fibrillation in patients undergoing cardiac surgery.
Answers are grounded in this paper and cite their sources.
LLTS reduces POAF after cardiac surgery; extends neuromodulation evidence for perioperative AF prevention.
Background: Postoperative atrial fibrillation (POAF) occurs in up to 40% of patients undergoing cardiac surgery. Invasive stimulation of the vagal nerve previously demonstrated a reduced risk of POAF. Therefore, we examined the antiarrhythmic and anti-inflammatory effects of noninvasive low-level transcutaneous electrical stimulation (LLTS) of the greater auricular nerve in a pilot trial including patients undergoing cardiac surgery. Methods: Patients were randomized into a sham (n=20) or a treatment group (n=20) for LLTS. After cardiac surgery, electrodes were applied in the triangular fossa of the ear. Stimulation (amplitude 1 mA, frequency 1 Hz for 40 minutes, followed by a 20 minutes break) was performed for up to 2 weeks after cardiac surgery. Heart rhythm was recorded continuously using an ECG during the observation period. CRP (C-reactive protein) and IL (interleukin)-6 plasma concentrations were measured immediately after surgery as well as on day 2 and 7 postsurgery. Results: Patients receiving LLTS had a significantly reduced occurrence of POAF (4 of 20) when compared with controls (11 of 20, P =0.022) during a similar mean Holter recording period. The median duration of POAF was comparable between the treatment and the control group (878 [249; 1660] minutes versus 489 [148; 1775] minutes; P =0.661). No effect of LLTS on CRP or IL-6 levels was detectable. Conclusions: LLTS of the greater auricular nerve may be a potential therapy for POAF. We demonstrated the feasibility to conduct a randomized trial of neurostimulation as an outlay for a multisite clinical trial.
No takes yet. Share an insight, caveat, or question.
Andreas et al. (2019) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: